BRPI0610336B8 - processo para preparar 5-(4-[4-(5-ciano-3-indolil)butil]-1-piperazinil)benzofuran-2-carboxa-mida ou seu sal fisiologicamente aceitável. - Google Patents
processo para preparar 5-(4-[4-(5-ciano-3-indolil)butil]-1-piperazinil)benzofuran-2-carboxa-mida ou seu sal fisiologicamente aceitável.Info
- Publication number
- BRPI0610336B8 BRPI0610336B8 BRPI0610336A BRPI0610336A BRPI0610336B8 BR PI0610336 B8 BRPI0610336 B8 BR PI0610336B8 BR PI0610336 A BRPI0610336 A BR PI0610336A BR PI0610336 A BRPI0610336 A BR PI0610336A BR PI0610336 B8 BRPI0610336 B8 BR PI0610336B8
- Authority
- BR
- Brazil
- Prior art keywords
- benzofuran
- indolyl
- cyano
- butyl
- carboxamide
- Prior art date
Links
- 150000003839 salts Chemical class 0.000 title abstract 5
- SGEGOXDYSFKCPT-UHFFFAOYSA-N vilazodone Chemical compound C1=C(C#N)C=C2C(CCCCN3CCN(CC3)C=3C=C4C=C(OC4=CC=3)C(=O)N)=CNC2=C1 SGEGOXDYSFKCPT-UHFFFAOYSA-N 0.000 title abstract 4
- 238000004519 manufacturing process Methods 0.000 title abstract 3
- 239000002253 acid Substances 0.000 abstract 4
- 150000001875 compounds Chemical class 0.000 abstract 2
- QHKJIJXBJCOABP-UHFFFAOYSA-N 1-benzofuran-2-carboxamide Chemical compound C1=CC=C2OC(C(=O)N)=CC2=C1 QHKJIJXBJCOABP-UHFFFAOYSA-N 0.000 abstract 1
- KAMHFQOKYXEWST-UHFFFAOYSA-N 3-(4-oxobutyl)-1h-indole-5-carbonitrile Chemical compound C1=C(C#N)C=C2C(CCCC=O)=CNC2=C1 KAMHFQOKYXEWST-UHFFFAOYSA-N 0.000 abstract 1
- YWBYYVAHAWQUDF-UHFFFAOYSA-N 3-(4-piperazin-1-ylbutyl)-1h-indole-5-carbonitrile Chemical compound C12=CC(C#N)=CC=C2NC=C1CCCCN1CCNCC1 YWBYYVAHAWQUDF-UHFFFAOYSA-N 0.000 abstract 1
- ACZGCWSMSTYWDQ-UHFFFAOYSA-N 3h-1-benzofuran-2-one Chemical compound C1=CC=C2OC(=O)CC2=C1 ACZGCWSMSTYWDQ-UHFFFAOYSA-N 0.000 abstract 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 238000006268 reductive amination reaction Methods 0.000 abstract 1
- 229910052723 transition metal Inorganic materials 0.000 abstract 1
- 150000003624 transition metals Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
- C07D307/82—Benzo [b] furans; Hydrogenated benzo [b] furans with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
- C07D307/84—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
- C07D307/82—Benzo [b] furans; Hydrogenated benzo [b] furans with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
- C07D307/84—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
- C07D307/85—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Indole Compounds (AREA)
- Furan Compounds (AREA)
Abstract
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
BR122020011626A BR122020011626B8 (pt) | 2005-04-26 | 2006-04-12 | processo para preparar 5-(4-[4-(5-ciano-3-indolil)butil]-1-piperazinil)benzofuran-2-carboxa-mida ou seu sal |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE102005019670.5 | 2005-04-26 | ||
DE102005019670A DE102005019670A1 (de) | 2005-04-26 | 2005-04-26 | Verfahren zur Herstellung von (5-(4-[4-(5-Cyano-3-indolyl)-butyl)-1-piperazinyl)-benzofuran-2-carboxamid |
PCT/EP2006/003344 WO2006114202A1 (de) | 2005-04-26 | 2006-04-12 | Verfahren zur herstellung von 5-(4-[4-(5-cyano-3-indolyl)-butyl]-1-piperazinyl)-benzofuran-2-carboxamid |
Publications (3)
Publication Number | Publication Date |
---|---|
BRPI0610336A2 BRPI0610336A2 (pt) | 2010-06-15 |
BRPI0610336B1 BRPI0610336B1 (pt) | 2020-09-24 |
BRPI0610336B8 true BRPI0610336B8 (pt) | 2021-05-25 |
Family
ID=36603535
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRPI0610336A BRPI0610336B8 (pt) | 2005-04-26 | 2006-04-12 | processo para preparar 5-(4-[4-(5-ciano-3-indolil)butil]-1-piperazinil)benzofuran-2-carboxa-mida ou seu sal fisiologicamente aceitável. |
BR122020011626A BR122020011626B8 (pt) | 2005-04-26 | 2006-04-12 | processo para preparar 5-(4-[4-(5-ciano-3-indolil)butil]-1-piperazinil)benzofuran-2-carboxa-mida ou seu sal |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR122020011626A BR122020011626B8 (pt) | 2005-04-26 | 2006-04-12 | processo para preparar 5-(4-[4-(5-ciano-3-indolil)butil]-1-piperazinil)benzofuran-2-carboxa-mida ou seu sal |
Country Status (21)
Country | Link |
---|---|
US (1) | US7799916B2 (pt) |
EP (1) | EP1874762B1 (pt) |
JP (2) | JP5113039B2 (pt) |
KR (1) | KR101310191B1 (pt) |
CN (1) | CN101163698B (pt) |
AT (1) | ATE420875T1 (pt) |
AU (1) | AU2006239569B2 (pt) |
BR (2) | BRPI0610336B8 (pt) |
CA (1) | CA2605758A1 (pt) |
CY (1) | CY1108904T1 (pt) |
DE (2) | DE102005019670A1 (pt) |
DK (1) | DK1874762T3 (pt) |
ES (1) | ES2320172T3 (pt) |
HK (1) | HK1116492A1 (pt) |
MX (1) | MX2007013258A (pt) |
PL (1) | PL1874762T3 (pt) |
PT (1) | PT1874762E (pt) |
RU (1) | RU2397981C2 (pt) |
SI (1) | SI1874762T1 (pt) |
WO (1) | WO2006114202A1 (pt) |
ZA (1) | ZA200710145B (pt) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102267985B (zh) * | 2011-06-15 | 2015-12-09 | 上海医药工业研究院 | 维拉佐酮或其盐酸盐的制备方法 |
CN102267932A (zh) * | 2011-06-15 | 2011-12-07 | 上海医药工业研究院 | 4-(5-氰基-1h-吲哚-3-基)丁基取代磺酸酯类化合物及其应用 |
CN102949364A (zh) * | 2011-08-30 | 2013-03-06 | 天津药物研究院 | 一种含有效成分盐酸维拉佐酮的缓释片 |
EP2809665A1 (en) * | 2012-02-01 | 2014-12-10 | Ranbaxy Laboratories Limited | Process for the preparation of vilazodone or its pharmaceutically acceptable salts |
WO2013168126A1 (en) | 2012-05-11 | 2013-11-14 | Dr.Reddys Laboratories Limited | Crystalline forms of vilazodone hydrochloride and vilazodone free base |
WO2013175361A1 (en) * | 2012-05-24 | 2013-11-28 | Ranbaxy Laboratories Limited | Process for the preparation of vilazodone hydrochloride |
CN102796037B (zh) * | 2012-08-09 | 2013-11-06 | 成都苑东药业有限公司 | 一种3-(4-(4-取代哌嗪)-1-丁酰基)吲哚-5-甲腈及其用途 |
WO2014028473A1 (en) * | 2012-08-13 | 2014-02-20 | Assia Chemical Industries Ltd. | New salts of vilazodone and solid state forms thereof |
CN102875538A (zh) * | 2012-10-16 | 2013-01-16 | 北京诚创思达医药科技有限公司 | 维拉唑酮或其盐酸盐的制备方法 |
WO2014061004A2 (en) * | 2012-10-19 | 2014-04-24 | Ranbaxy Laboratories Limited | Process for the preparation of vilazodone or pharmaceutically acceptable salt thereof |
WO2014064715A2 (en) * | 2012-10-22 | 2014-05-01 | Cadila Healthcare Limited | Amorphous form of vilazodone hydrochloride and process for preparing thereof |
WO2014199313A1 (en) | 2013-06-12 | 2014-12-18 | Lupin Limited | Substantially pure vilazodone hydrochloride and a process thereof |
CN105017233A (zh) * | 2014-04-23 | 2015-11-04 | 天津药物研究院 | 一种盐酸维拉佐酮晶体、其制备方法、药物组合物和用途 |
CN103965148B (zh) * | 2014-05-15 | 2016-04-06 | 北京北陆药业股份有限公司 | 一种5-(哌嗪-1-基)苯并呋喃-2-羧酸乙酯的合成方法 |
CN107501159B (zh) * | 2017-08-14 | 2020-11-24 | 连云港恒运药业有限公司 | 维拉佐酮中间体3-(4-氯丁基)-5-氰基吲哚合成方法 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE4333254A1 (de) | 1993-09-30 | 1995-04-06 | Merck Patent Gmbh | Piperidine und Piperazine |
DE19514567A1 (de) * | 1995-04-20 | 1996-10-24 | Merck Patent Gmbh | Benzofurane |
DE10217006A1 (de) * | 2002-04-16 | 2003-11-06 | Merck Patent Gmbh | Substituierte Indole |
DE10252102A1 (de) * | 2002-11-08 | 2004-05-27 | Merck Patent Gmbh | Indolderivate |
-
2005
- 2005-04-26 DE DE102005019670A patent/DE102005019670A1/de not_active Withdrawn
-
2006
- 2006-04-12 PT PT06724257T patent/PT1874762E/pt unknown
- 2006-04-12 US US11/912,584 patent/US7799916B2/en active Active
- 2006-04-12 BR BRPI0610336A patent/BRPI0610336B8/pt active IP Right Grant
- 2006-04-12 AT AT06724257T patent/ATE420875T1/de active
- 2006-04-12 RU RU2007143504/04A patent/RU2397981C2/ru not_active IP Right Cessation
- 2006-04-12 SI SI200630203T patent/SI1874762T1/sl unknown
- 2006-04-12 ES ES06724257T patent/ES2320172T3/es active Active
- 2006-04-12 MX MX2007013258A patent/MX2007013258A/es active IP Right Grant
- 2006-04-12 JP JP2008508108A patent/JP5113039B2/ja active Active
- 2006-04-12 CA CA002605758A patent/CA2605758A1/en not_active Abandoned
- 2006-04-12 DE DE502006002659T patent/DE502006002659D1/de active Active
- 2006-04-12 PL PL06724257T patent/PL1874762T3/pl unknown
- 2006-04-12 WO PCT/EP2006/003344 patent/WO2006114202A1/de active Application Filing
- 2006-04-12 KR KR1020077027178A patent/KR101310191B1/ko not_active IP Right Cessation
- 2006-04-12 BR BR122020011626A patent/BR122020011626B8/pt active IP Right Grant
- 2006-04-12 DK DK06724257T patent/DK1874762T3/da active
- 2006-04-12 AU AU2006239569A patent/AU2006239569B2/en active Active
- 2006-04-12 EP EP06724257A patent/EP1874762B1/de active Active
- 2006-04-12 CN CN2006800138161A patent/CN101163698B/zh active Active
-
2007
- 2007-11-26 ZA ZA200710145A patent/ZA200710145B/xx unknown
-
2008
- 2008-06-24 HK HK08106976.7A patent/HK1116492A1/xx not_active IP Right Cessation
-
2009
- 2009-03-23 CY CY20091100335T patent/CY1108904T1/el unknown
-
2012
- 2012-08-08 JP JP2012175557A patent/JP5735465B2/ja active Active
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BRPI0610336B8 (pt) | processo para preparar 5-(4-[4-(5-ciano-3-indolil)butil]-1-piperazinil)benzofuran-2-carboxa-mida ou seu sal fisiologicamente aceitável. | |
BRPI0407672A (pt) | processos para preparar imatinib e um sal de adição ácida deste, sais de adição ácida de imatinib, composição farmaceuticamente aceitável deste, imatinib e uso deste | |
BRPI0910178A8 (pt) | "composto de fórmula (i), composto de fórmula (vi), composição de fungicidas e método para o controle de fungo fitopatogênico de culturas" | |
BRPI0412347A (pt) | 2-aminofenil-4-fenilpiridinas como inibidores de quinase | |
NO20081905L (no) | Benzotiazolcyklobutylaminderivater og deres anvendelse som histamin-3-reseptorligander | |
NO20075626L (no) | Heteroarylbenzamid-derivater for anvendelse som GLK-aktivatorer i behandling av diabetes | |
BR0317455A (pt) | Derivados de pirrol-pirazol substituìdos como inibidores de quinase | |
BRPI0613570B8 (pt) | composto, composição farmacêutica e uso de um composto ou um sal farmaceuticamente aceitável do mesmo | |
BRPI0519597A2 (pt) | derivados de (3r, 6r)-3-(2, 3-diidro-1h-inden-2-il)-2, 5-piperazinadiona 1, 6-substituÍda como antagonistas de receptores de oxitocina para o tratamento de parto prematuro, dismenorrÉia e endometriose | |
ATE373009T1 (de) | Verfahren zur vorbereitung von telithromycin | |
BRPI0612957B8 (pt) | composto, processos de preparação de compostos, composição farmacêutica e uso de um composto | |
EA200801775A1 (ru) | Пиридин-4-илметиламиды для борьбы с вредителями | |
DK1989174T3 (da) | Substituerede cyclohexylmethyl-derivater | |
BRPI0410238A (pt) | compostos orgánicos | |
NO20081329L (no) | Fremstilling av modifiserte lignocellulosematerialer | |
BR0112582A (pt) | Sulfonamidas de ciclilamina como agonistas de receptores beta-3 adrenérgicos | |
NO20063865L (no) | Heterocyklisk substituerte 7-amino-4-kinolon-3-karboksylsyrederivater, fremgangsmate for fremstilling derav og deres anvendelse som medikamenter | |
BR0213185A (pt) | Derivados de 3-[4-(heterociclila substituìda)-pirrol-2-ilmetilideno]2-indolinona como inibidores de cinase | |
NZ601508A (en) | Substituted naphthalenyl-pyrimidine compounds and the use thereof in the treatment of cancer | |
BRPI0414780B8 (pt) | composto, uso do mesmo, composição farmacêutica, e, método para preparar um composto | |
BR0308419A (pt) | Derivados de azetidina como antagonistas do receptor ccr-3 | |
SV2008002512A (es) | Derivados de aminoacidos ref. pc32769a | |
BRPI0512558A (pt) | compostos quìmicos | |
BR0115865A (pt) | Derivados de piperazina 1,4-di-substituìda utilizáveis como bloqueadores de receptores adrenérgicos alfa1 uro-seletivos | |
BRPI0607720A2 (pt) | processo aperfeiçoado para a preparação de diidrobenzofuranos substituìdos por (propenil dissubstituìdos) fenilalquila |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B15K | Others concerning applications: alteration of classification |
Free format text: A CLASSIFICACAO ANTERIOR ERA: C07D 405/06 Ipc: C07D 405/14 (2006.01) |
|
B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] |
Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001, QUE MODIFICOU A LEI NO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUENCIA PREVIA DA ANVISA. CONSIDERANDO A APROVACAO DOS TERMOS DO PARECER NO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDENCIAS CABIVEIS. |
|
B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] | ||
B06A | Patent application procedure suspended [chapter 6.1 patent gazette] | ||
B09A | Decision: intention to grant [chapter 9.1 patent gazette] | ||
B16A | Patent or certificate of addition of invention granted [chapter 16.1 patent gazette] |
Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 24/09/2020, OBSERVADAS AS CONDICOES LEGAIS. |
|
B16C | Correction of notification of the grant [chapter 16.3 patent gazette] |
Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 12/04/2006 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF |